EDNRA and membranous glomerulonephritis: Our study is the first worldwide evaluation of PAR 1 in specific kidney diseases, and we are the first to find correlations between PAR 1 and anti-PAR 1 in FSGS and correlations between anti-PAR 1 and anti-ETAR in membranous nephropathy, FSGS, and IgA nephropathy.